SBIR/STTR Research Award

Pan-specific tools and reagents for the enrichment of sialo-glycans

Award identifier a1349403b7456e3ea15af10dcb281446ee6ee730eda11549738a96a4b1d65d41Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,934

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
LECTENZ BIO, INC.
Proposal award date
2018-09-01
Contract end date
2020-02-29
UEI
JTGCK219C6F4
Solicitation number
PA15-052
Topic code
100

Research abstract

PROJECT SUMMARY Glycans have several distinct properties that make their development as disease biomarkers appealingFirstlytheir location on cell surfaces makes them the first point of contact for cellular interactionsand thus they are crucial in the control of normal metabolic processesand converselythey function as pathogen adhesion receptorsSecondlyspecific glycan structures that are not presentor are in low amounts in normal stateproliferate or alter their sequence in disease statesAndlastlychanges in glycosylation may be found in many proteinsincluding those that are highly abundantThus changes in the normal levels of glycan structuressuch as terminal sialic acidmay be markers of disease statesNew highly specific reagents are required in order to overcome current limitations in the discovery and exploitation of disease related glycansUsing structurally guided genetic manipulationswe are converting the NanB sialidase from Spneumococcus into a high specificity affinity reagent for the detection of all types of sialic acid modifications of glycopeptides and glycoproteinsBecause such a protein has lectin like propertiesbut is derived from an enzymeit is called a andquot Lectenz andquotA NanB Lectenzaddresses a key need in disease glycomarker detectionnamelya robust and easy to produce reagent specific for detecting all types of sialylated glycansThis reagent could be employed in an affinity matrix for sample enrichmentwhich in conjunction with existing MS based methods could provide linkage informationGlycopeptide sample enrichment aids glycomic analyses by eliminating non glycosylated peptideswhich would otherwise attenuate the signals from glycopeptides that have low ionization efficiencyGlycosylation site mapping is essential in fully characterizing and exploiting glycans as markers of specific disease statesbut at presentno reagent exists that can detect sialylated glycansindependent of the type of linkage associated with the sialic acidThusat presenta number of reagents with varying specificities and affinities must be employed to capture or detect all forms of sialylated glycansLectenzoffer numerous advantages over plant lectinsthey are engineered to be high affinity and yet retain the exquisite substrate specificity of the endogenous enzymethey may be efficiently producedand for human homologues have the potential to be employed in vivo with low toxicityWhereas some aspects of Lectenzdevelopment parallel those of antibody evolutionLectenzhave the tremendous benefit of employing a protein na ve template that has the desired specificity PROJECT NARRATIVE Using structurally guided genetic manipulationswe are converting carbohydrate processing enzymes into a high specificity affinity reagentscalled Lectenzfor the detection of disease related modifications of glycopeptides and glycoproteinsHere we are developing a LectenzSia PSspecific for the enrichment of biologically important glycans that contain all forms of sialic acidThe principle advantages of engineered Lectenzover other reagentssuch as antibodies or lectinsis that they have exquisite substrate specificity that is not context dependentthey may be evolved to have desirable binding kineticsand that they may be efficiently produced as monomeric proteins

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

18 SBIR/STTR records share this UEI (2009–2025). Reported award amounts total $14,474,759. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.